🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Tsinghua University clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Tsinghua University as lead sponsor. Synced 26 Sep 2026
9Current trials
3Recruiting now
1Drug in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Tsinghua University is the lead sponsor of 9 current clinical trials in our China register. 3 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are TUDCA (Tauroursodeoxycholic Acid) Supplementation. The most-studied condition is Artificial Intelligence (AI).

ClinicalTrials.gov trials by status

  • Recruiting333%
  • Not yet open556%
  • Active, closed111%

Trials by phase

  • Not applicable889%
  • Observational111%
01

Clinical trials sponsored by Tsinghua University

9 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Clinical Intelligent Management System Pragmatic RCT
NCT06893068 · ClinicalTrials.gov ↗ · Primary Care Diseases
Not applicable Recruiting 2025-04 China
Usability User Testing of the Easy-EyeFM AI Platform
NCT06834906 · ClinicalTrials.gov ↗ · Ocular Diseases
Not applicable Recruiting 2025-01 China
Clinical Intelligent Management System - Multilingual Exploration
NCT06923410 · ClinicalTrials.gov ↗ · Primary Care Diseases
Not applicable Recruiting 2025-04 China
AI-driven Automated Biomedical Research
NCT06962423 · ClinicalTrials.gov ↗ · Biomedical Research, Artificial Intelligence (AI)
Not applicable Not yet open 2025-05 China
Evaluation of AI-Generated Clinical Advice by Physicians
NCT06980467 · ClinicalTrials.gov ↗ · Artificial Intelligence (AI)
Not applicable Not yet open 2025-05 China
Effect of Oral Supplement on Influenza Vaccine Long-term Response
NCT07357467 · ClinicalTrials.gov ↗ · Influenza, Immunosenescence
Observational Not yet open 2026-03 China
Effect of Oral Supplements for Influenza Vaccine Response
NCT06827873 · ClinicalTrials.gov ↗ · Influenza Vaccine Response
Not applicable Not yet open 2025-02 China
Effect of Squash Exercise Intervention on Sleep and Mental Health Among Young Adults
NCT06839417 · ClinicalTrials.gov ↗ · Sleep, Mental Health, Exercise
Not applicable Not yet open 2025-03 China
Performance Evaluation of Artificial Intelligence Screening Model in Coronary Heart Disease Detection
NCT06658600 · ClinicalTrials.gov ↗ · Coronary Heart Disease
Not applicable Active, closed 2025-01 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Tsinghua University trials

1 compound

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Tsinghua University trials

11 conditions
Artificial Intelligence (AI)2Primary Care Diseases2Biomedical Research1Influenza1Immunosenescence1Influenza Vaccine Response1Sleep1Mental Health1Exercise1Coronary Heart Disease1Ocular Diseases1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China93

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Artificial Intelligence (AI)

SponsorTrials
Shanghai Jiao Tong University Affiliated Sixth People's Hospital2

Sponsors with the most current trials registered for this condition.

06

Questions about Tsinghua University trials

How many clinical trials does Tsinghua University sponsor?

Tsinghua University is the lead sponsor of 9 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Tsinghua University trials recruiting?

Yes. 3 of its 9 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Tsinghua University testing?

Its current trials name 1 drug or biological as interventions. The most frequent are TUDCA (Tauroursodeoxycholic Acid) Supplementation (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.